Azithromycin

Generic Name: Azithromycin

Brand Names: Azasite, Zithromax, Zmax

Drug Type: Small Molecule

Chemical Formula: C_₃₈H_₇₂N_₂O_₁₂

CAS Number: 83905-01-5

Unique Ingredient Identifier: J2KLZ20U1M

Background: Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration . It was initially approved by the FDA in 1991 .
...

Indication: Azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in order to prevent the development antimicrobial resistance and maintain the efficacy of azithromycin .
...

Associated Conditions: Acute Bacterial Sinusitis (ABS), Acute Otitis Media (AOM), Acute bacterial exacerbation of COPD caused by Haemophilus Influenza Infections, Moraxella Catarrhalis Infection, Streptococcus Pneumoniae Infections, Bacterial Conjunctivitis, Bacterial Sinusitis, Cervicitis, Chancroid, Community Acquired Pneumonia (CAP), Genital Ulcer Disease (GUD), Pelvic Inflammatory Disease (PID), Pharyngitis, Streptococcal Pharyngitis, Tonsillitis bacterial, Tonsillitis streptococcal, Traveler's Diarrhea, Uncomplicated Skin and Skin Structure Infections, Urethritis

Associated Therapies: -

Clinical Trials

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Phase 2

Recruiting

Conditions: Lung Diseases
Bronchiolitis Obliterans
Chronic Graft Versus Host Disease
Bronchiolitis Obliterans Syndrome

Interventions: Drug: Belumosudil
Drug: Fluticasone
Drug: Azithromycin
Drug: Prednisone
Drug: Montelukast

First Posted Date: 2023-06-28

Last Posted Date: 2024-08-16

Lead Sponsor: Dana-Farber Cancer Institute

Target Recruit Count: 45

Registration Number: NCT05922761

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

and more 2 locations

Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Not Applicable

Not yet recruiting

Conditions: Idiopathic Pulmonary Fibrosis

Interventions: Drug: Methylprednisolone
Drug: Azithromycin

First Posted Date: 2023-05-06

Last Posted Date: 2023-05-06

Lead Sponsor: Assiut University

Target Recruit Count: 30

Registration Number: NCT05842681

Locations: 🇪🇬
Assiut university-Faculty of Medicine, Assiut, Egypt

Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris

Phase 3

Completed

Conditions: Acne Vulgaris

Interventions: Drug: Probiotic Formula
Drug: Azithromycin
Drug: Benzoyl Peroxide 4 % Topical Cream

First Posted Date: 2022-11-29

Last Posted Date: 2022-12-05

Lead Sponsor: Pak Emirates Military Hospital

Target Recruit Count: 75

Registration Number: NCT05629468

Locations: 🇵🇰
PEMH, Rawalpindi, Punjab, Pakistan

Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant Asthma

Phase 4

Not yet recruiting

Conditions: Asthma
Effect of Drug
Chest Syndrome
Azithromycin

Interventions: Drug: ICS/LABA
Drug: Azithromycin

First Posted Date: 2022-10-27

Last Posted Date: 2022-11-04

Lead Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Target Recruit Count: 248

Registration Number: NCT05596721

Locations: 🇨🇳
The First Affiliated Hospital,Guangzhou Medical University, Guangzhou, Guangdong, China
🇨🇳
The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
🇨🇳
Qilu Hospital, Shandong University, Jinan, Shandong, China

and more 10 locations